Risperidone and escitalopram co-administration: A potential treatment of schizophrenia symptoms with less side effects-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Risperidone and escitalopram co-administration: A potential treatment of schizophrenia symptoms with less side effects

Published:2017-02 Issue:1 Volume:69 Page:13-21
ISSN:1734-1140
Container-title:Pharmacological Reports
language:en
Short-container-title:Pharmacological Reports

Author:

Kamińska Katarzyna,Noworyta-Sokołowska Karolina,Jurczak Alexandra,Górska Anna,Rogóż Zofia,Gołembiowska Krystyna

Funder

Institute of Pharmacology PAS

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,General Medicine

Reference37 articles.

1. Escitalopram in the treatment of negative symptoms in patients with chronic schizophrenia: a randomized double-blind placebo-controlled trial;Iancu;Psychiatry Res,2010

2. Augmentation with antidepressants in schizophrenia treatment: benefit or risk;Mao;Neuropsychiatr Dis Treat,2015

3. Efficacy of antidepressants in treating the negatie symptoms of chronic schizophrenia: meta-analysis;Singh;Br J Psychiatry,2010

4. In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems;Meltzer,2008

5. Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding;Schotte;Psychopharmacology (Berl),1996

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dopamine D2 receptors in pyramidal neurons in the medial prefrontal cortex regulate social behavior;Pharmacological Research;2024-01

2. PAMAM-Calix-Dendrimers: Second Generation Synthesis, Fluorescent Properties and Catecholamines Binding;Pharmaceutics;2022-12-08

3. Comparative Effect of Escitalopram and Citalopram on Depressive Symptoms of Patients with Schizophrenia: A Double-Blind Randomized Controlled Trial;Global Journal of Medical, Pharmaceutical, and Biomedical Update;2022-10-15

4. The Influence of Genetic Variations and Drug Interactions Based on Metabolism of Antidepressants and Anticonvulsants;Current Drug Metabolism;2021-07

5. A UPLC-MS/MS Assay for Simultaneous Determination of Two Antipsychotics and Two Antidepressants in Human Plasma and Its Application in Clinic;Current Pharmaceutical Biotechnology;2020-01-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3